secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001493152-24-011606
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health appoints COO and CFO Priya Prasad to board of directors
-------------------------------------------------------------------

- On March 27, 2024, Syra Health Corp. appointed Priya Prasad, its COO and CFO, as a director.
- The appointment was disclosed in a Form 8-K filed with the SEC on March 28, 2024.
- Syra Health is an emerging growth company listed on Nasdaq under ticker SYRA.
- Prasad will continue serving as COO and CFO in addition to her new board role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224011606/0001493152-24-011606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224011606/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer